Endovascular treatment of subdural haematoma in patient under anti-platelet therapy: a case report

IntroductionThe incidence of chronic subdural haematoma (cSDH) is relatively high among the elderly population. Other known risk factors for cSDH include male sex, dependency on anti-platelet or anticoagulant medication, and chronic alcoholism. Although, the standard mode of treatment for cSDH is su...

Full description

Saved in:
Bibliographic Details
Published in:Annals of medicine and surgery (2012) Vol. 86; no. 2; pp. 1066 - 1071
Main Authors: Thapa, Paras, Bhattarai, Ganesh, Kharel, Santosh Kumar, Kunwar, Pratiksha, Bhandari, Sagar, Bhandari, Shailaj, Shilpakar, Sushil, Thapa, Bikash, Thapa, Ajit, Sharma, Mohan Raj
Format: Report
Language:English
Published: 01-02-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionThe incidence of chronic subdural haematoma (cSDH) is relatively high among the elderly population. Other known risk factors for cSDH include male sex, dependency on anti-platelet or anticoagulant medication, and chronic alcoholism. Although, the standard mode of treatment for cSDH is surgery, embolization of the middle meningeal artery (MMA), either upfront or as an adjunct to surgical evacuation can be used for the treatment of cSDH.Case presentationThe authors present a case of a 75-year-old female with prior history of posterior-lateral wall myocardial infarction (MI) eight years back presented to our centre with the chief complaints of a gradual onset of cough and headache for 2 months. The patient had no history of trauma, loss of consciousness, seizures, and vomiting. There was no history of diabetes, hypertension, pulmonary tuberculosis, and other chronic illness.DiscussionThe concurrent use of anti- platelet drug during a surgical procedure can make the treatment challenging. Endovascular treatment can be a primary treatment modality in such situation.ConclusionElimination of blood supply by middle meningeal artery embolization is emerging as a safe, minimally invasive alternative to treat cSDH.
Bibliography:ObjectType-Case Study-2
content type line 59
SourceType-Reports-1
ObjectType-Report-1
ISSN:2049-0801
2049-0801
DOI:10.1097/MS9.0000000000001516